19/04/2021The preliminary trial results of a novel radiopharmaceutical for PET imaging of inflammation developed at the University of Turku, Finland, have been published. The compound, which targets the vascular adhesion protein 1 (VAP-1) that regulates inflammatory cell traffic, is the first radiopharmaceutical that has been developed completely in Finland and has advanced to clinical trials.
23/11/2020Active implants such as pacemakers revolutionized healthcare decades ago. But they also have disadvantages: their size and relatively short life span, for example. At Fraunhofer IZM, research is therefore being conducted on durable microimplants that stimulate nerve cells electrically in a targeted manner and are even to be used to treat multiple sclerosis.